Related Experiment Video
Updated: Jun 17, 2026

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections
Published on: October 31, 2017
Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents
Carol L Joanis1, Catherine W Hart
1Behavioral and Biomedical Research Department, Family Health International, P.O. Box 13950, Research Triangle Park, NC 27709, USA. cjoanis@fhi.org
Abstract:
Vaginal microbicides could reduce incidence of HIV. However, the current method of delivering gel formulations (standard applicator) can result in acceptability concerns/issues. This study evaluated the concept of using a non-woven textile material (modified tampon) for vaginal drug delivery. The study was nested within a Phase I randomized safety trial of lime juice concentrations used intra-vaginally. Of 47 women completing the safety trial, 16 were interviewed about their experiences. Overall, women found the concept of non-woven materials for vaginal drug delivery acceptable for use in delivering yeast medications (13 of 16) and STI/HIV preventives (10 of 16).
Related Concept Videos
Intrauterine Drug Delivery Systems
Transdermal Drug Delivery Systems
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Oral Drug Delivery Systems: Introduction
Modified-Release Drug Delivery Systems: Drug Release Characteristics

